The Latest Discovery by Dicerna Pharmaceuticals (NASDAQ:DRNA)
Por um escritor misterioso
Descrição
Press Coverage – Maiwald
Royalty Pharma Acquires OXLUMO From Dicerna for $240 Million
Douglas Fambrough - Medtech Alert
Lilly and Dicerna Announce RNAi Licensing and Research
Novo Nordisk to Acquire Dicerna
Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi
Diving Into Dicerna Pharmaceuticals (NASDAQ:DRNA)
Articles about Dicerna Pharmaceuticals
Next-Gen Partnerships: The Ascent of Advanced Therapies
Company Overview: Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA
de
por adulto (o preço varia de acordo com o tamanho do grupo)
